PVLA
Palvella Therapeutics, Inc. - Common Stock (PVLA)
$85
About Palvella Therapeutics, Inc. - Common Stock (PVLA)
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.
Details
Daily high
$166.73
Daily low
$153.40
Price at open
$166.73
52 Week High
$166.73
52 Week Low
$72.22
Market cap
2.3B
Dividend yield
-
Volume
269,521
Avg. volume
251,427
P/E ratio
-33.56
Palvella Therapeutics, Inc. - Common Stock News
Details
Daily high
$166.73
Daily low
$153.40
Price at open
$166.73
52 Week High
$166.73
52 Week Low
$72.22
Market cap
2.3B
Dividend yield
-
Volume
269,521
Avg. volume
251,427
P/E ratio
-33.56